Loading…

Fragmented responsibility: views of Israeli HCPs regarding patient recontact following variant reclassification

While genomic medicine is becoming an important part of patient care with an ever-increasing diagnostic yield, recontacting patients after reclassification of variants of uncertain clinical significance (VUSs) remains a major challenge. Although periodical reinterpretation of VUSs is highly desired,...

Full description

Saved in:
Bibliographic Details
Published in:Journal of community genetics 2022-02, Vol.13 (1), p.13-18
Main Authors: Fridman, Alma Levin, Raz, Aviad, Timmermans, Stefan, Shkedi-Rafid, Shiri
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c474t-867792e8ccf67a29ee6335ac747256c91d7c872c8a1b6933d5fae8535c8dd9ee3
cites cdi_FETCH-LOGICAL-c474t-867792e8ccf67a29ee6335ac747256c91d7c872c8a1b6933d5fae8535c8dd9ee3
container_end_page 18
container_issue 1
container_start_page 13
container_title Journal of community genetics
container_volume 13
creator Fridman, Alma Levin
Raz, Aviad
Timmermans, Stefan
Shkedi-Rafid, Shiri
description While genomic medicine is becoming an important part of patient care with an ever-increasing diagnostic yield, recontacting patients after reclassification of variants of uncertain clinical significance (VUSs) remains a major challenge. Although periodical reinterpretation of VUSs is highly desired, recontacting former patients with new classifications is commonly not fulfilled in practice. We draw on semi-structured interviews with 20 Israeli healthcare professionals and stakeholders involved in communicating the results of genome-wide sequencing to patients. Findings show agreement that an individual health care professional cannot address the task of recontacting patients after re-classification, and that responsibility should be shared among the medical specialties, laboratory scientists, as well as patients. In the absence of established guidelines, many respondents suggested that the patient should be informed about reclassification during a follow-up contact but they disagreed who should be responsible for informing the patient. HCPs agreed that the solution to this challenge involves a centralized automated database that is accessible, continuously updated, and facilitates retrospective as well as prospective flagging of reclassification for patients who can benefit from this information. National and international policies providing concrete guidelines on the optimal way to recontact patients with new valuable genomic information are needed.
doi_str_mv 10.1007/s12687-021-00556-x
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8491183</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2579379892</sourcerecordid><originalsourceid>FETCH-LOGICAL-c474t-867792e8ccf67a29ee6335ac747256c91d7c872c8a1b6933d5fae8535c8dd9ee3</originalsourceid><addsrcrecordid>eNp9kctuFDEQRS0URKKQH2ARtcQmmwY_2i8WSGiUlxQJFiCxs2rc7o4jjz3YPZPk7-PQQ4As4o0t31O3qnQRekfwB4Kx_FgIFUq2mJIWY85Fe_cKHRAlVCswJnu7NyP45z46KuUG18MY4YK_QfusE1hLSg5QOsswrlycXN9kV9YpFr_0wU_3n5qtd7elSUNzWTK44JuLxbdSqRFy7-PYrGHytbL-2BQnsFMzpBDS7aO2hexh1gKU4gdvK53iW_R6gFDc0e4-RD_OTr8vLtqrr-eXiy9Xre1kN7VKSKmpU9YOQgLVzgnGOFjZScqF1aSXVklqFZCl0Iz1fACnOONW9X2l2SH6PPuuN8uV622dM0Mw6-xXkO9NAm_-V6K_NmPaGtVpQhSrBic7g5x-bVyZzMoX60KA6NKmGMqlZlIrTSv6_hl6kzY51vUMFZQJXOfilaIzZXMqJbvhaRiCzWOkZo7U1EjN70jNXS06_neNp5I_AVaAzUCpUhxd_tv7BdsHVciv8A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2623605355</pqid></control><display><type>article</type><title>Fragmented responsibility: views of Israeli HCPs regarding patient recontact following variant reclassification</title><source>Open Access: PubMed Central</source><source>Springer Nature</source><creator>Fridman, Alma Levin ; Raz, Aviad ; Timmermans, Stefan ; Shkedi-Rafid, Shiri</creator><creatorcontrib>Fridman, Alma Levin ; Raz, Aviad ; Timmermans, Stefan ; Shkedi-Rafid, Shiri</creatorcontrib><description>While genomic medicine is becoming an important part of patient care with an ever-increasing diagnostic yield, recontacting patients after reclassification of variants of uncertain clinical significance (VUSs) remains a major challenge. Although periodical reinterpretation of VUSs is highly desired, recontacting former patients with new classifications is commonly not fulfilled in practice. We draw on semi-structured interviews with 20 Israeli healthcare professionals and stakeholders involved in communicating the results of genome-wide sequencing to patients. Findings show agreement that an individual health care professional cannot address the task of recontacting patients after re-classification, and that responsibility should be shared among the medical specialties, laboratory scientists, as well as patients. In the absence of established guidelines, many respondents suggested that the patient should be informed about reclassification during a follow-up contact but they disagreed who should be responsible for informing the patient. HCPs agreed that the solution to this challenge involves a centralized automated database that is accessible, continuously updated, and facilitates retrospective as well as prospective flagging of reclassification for patients who can benefit from this information. National and international policies providing concrete guidelines on the optimal way to recontact patients with new valuable genomic information are needed.</description><identifier>ISSN: 1868-310X</identifier><identifier>EISSN: 1868-6001</identifier><identifier>DOI: 10.1007/s12687-021-00556-x</identifier><identifier>PMID: 34609721</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Biomedical and Life Sciences ; Biomedicine ; Epidemiology ; Gene Function ; Gene Therapy ; Genomics ; Health care ; Human Genetics ; Original ; Original Article ; Patients ; Public Health ; Reclassification</subject><ispartof>Journal of community genetics, 2022-02, Vol.13 (1), p.13-18</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021</rights><rights>2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c474t-867792e8ccf67a29ee6335ac747256c91d7c872c8a1b6933d5fae8535c8dd9ee3</citedby><cites>FETCH-LOGICAL-c474t-867792e8ccf67a29ee6335ac747256c91d7c872c8a1b6933d5fae8535c8dd9ee3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491183/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491183/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34609721$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fridman, Alma Levin</creatorcontrib><creatorcontrib>Raz, Aviad</creatorcontrib><creatorcontrib>Timmermans, Stefan</creatorcontrib><creatorcontrib>Shkedi-Rafid, Shiri</creatorcontrib><title>Fragmented responsibility: views of Israeli HCPs regarding patient recontact following variant reclassification</title><title>Journal of community genetics</title><addtitle>J Community Genet</addtitle><addtitle>J Community Genet</addtitle><description>While genomic medicine is becoming an important part of patient care with an ever-increasing diagnostic yield, recontacting patients after reclassification of variants of uncertain clinical significance (VUSs) remains a major challenge. Although periodical reinterpretation of VUSs is highly desired, recontacting former patients with new classifications is commonly not fulfilled in practice. We draw on semi-structured interviews with 20 Israeli healthcare professionals and stakeholders involved in communicating the results of genome-wide sequencing to patients. Findings show agreement that an individual health care professional cannot address the task of recontacting patients after re-classification, and that responsibility should be shared among the medical specialties, laboratory scientists, as well as patients. In the absence of established guidelines, many respondents suggested that the patient should be informed about reclassification during a follow-up contact but they disagreed who should be responsible for informing the patient. HCPs agreed that the solution to this challenge involves a centralized automated database that is accessible, continuously updated, and facilitates retrospective as well as prospective flagging of reclassification for patients who can benefit from this information. National and international policies providing concrete guidelines on the optimal way to recontact patients with new valuable genomic information are needed.</description><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Epidemiology</subject><subject>Gene Function</subject><subject>Gene Therapy</subject><subject>Genomics</subject><subject>Health care</subject><subject>Human Genetics</subject><subject>Original</subject><subject>Original Article</subject><subject>Patients</subject><subject>Public Health</subject><subject>Reclassification</subject><issn>1868-310X</issn><issn>1868-6001</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kctuFDEQRS0URKKQH2ARtcQmmwY_2i8WSGiUlxQJFiCxs2rc7o4jjz3YPZPk7-PQQ4As4o0t31O3qnQRekfwB4Kx_FgIFUq2mJIWY85Fe_cKHRAlVCswJnu7NyP45z46KuUG18MY4YK_QfusE1hLSg5QOsswrlycXN9kV9YpFr_0wU_3n5qtd7elSUNzWTK44JuLxbdSqRFy7-PYrGHytbL-2BQnsFMzpBDS7aO2hexh1gKU4gdvK53iW_R6gFDc0e4-RD_OTr8vLtqrr-eXiy9Xre1kN7VKSKmpU9YOQgLVzgnGOFjZScqF1aSXVklqFZCl0Iz1fACnOONW9X2l2SH6PPuuN8uV622dM0Mw6-xXkO9NAm_-V6K_NmPaGtVpQhSrBic7g5x-bVyZzMoX60KA6NKmGMqlZlIrTSv6_hl6kzY51vUMFZQJXOfilaIzZXMqJbvhaRiCzWOkZo7U1EjN70jNXS06_neNp5I_AVaAzUCpUhxd_tv7BdsHVciv8A</recordid><startdate>20220201</startdate><enddate>20220201</enddate><creator>Fridman, Alma Levin</creator><creator>Raz, Aviad</creator><creator>Timmermans, Stefan</creator><creator>Shkedi-Rafid, Shiri</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220201</creationdate><title>Fragmented responsibility: views of Israeli HCPs regarding patient recontact following variant reclassification</title><author>Fridman, Alma Levin ; Raz, Aviad ; Timmermans, Stefan ; Shkedi-Rafid, Shiri</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c474t-867792e8ccf67a29ee6335ac747256c91d7c872c8a1b6933d5fae8535c8dd9ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Epidemiology</topic><topic>Gene Function</topic><topic>Gene Therapy</topic><topic>Genomics</topic><topic>Health care</topic><topic>Human Genetics</topic><topic>Original</topic><topic>Original Article</topic><topic>Patients</topic><topic>Public Health</topic><topic>Reclassification</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fridman, Alma Levin</creatorcontrib><creatorcontrib>Raz, Aviad</creatorcontrib><creatorcontrib>Timmermans, Stefan</creatorcontrib><creatorcontrib>Shkedi-Rafid, Shiri</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of community genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fridman, Alma Levin</au><au>Raz, Aviad</au><au>Timmermans, Stefan</au><au>Shkedi-Rafid, Shiri</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fragmented responsibility: views of Israeli HCPs regarding patient recontact following variant reclassification</atitle><jtitle>Journal of community genetics</jtitle><stitle>J Community Genet</stitle><addtitle>J Community Genet</addtitle><date>2022-02-01</date><risdate>2022</risdate><volume>13</volume><issue>1</issue><spage>13</spage><epage>18</epage><pages>13-18</pages><issn>1868-310X</issn><eissn>1868-6001</eissn><abstract>While genomic medicine is becoming an important part of patient care with an ever-increasing diagnostic yield, recontacting patients after reclassification of variants of uncertain clinical significance (VUSs) remains a major challenge. Although periodical reinterpretation of VUSs is highly desired, recontacting former patients with new classifications is commonly not fulfilled in practice. We draw on semi-structured interviews with 20 Israeli healthcare professionals and stakeholders involved in communicating the results of genome-wide sequencing to patients. Findings show agreement that an individual health care professional cannot address the task of recontacting patients after re-classification, and that responsibility should be shared among the medical specialties, laboratory scientists, as well as patients. In the absence of established guidelines, many respondents suggested that the patient should be informed about reclassification during a follow-up contact but they disagreed who should be responsible for informing the patient. HCPs agreed that the solution to this challenge involves a centralized automated database that is accessible, continuously updated, and facilitates retrospective as well as prospective flagging of reclassification for patients who can benefit from this information. National and international policies providing concrete guidelines on the optimal way to recontact patients with new valuable genomic information are needed.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>34609721</pmid><doi>10.1007/s12687-021-00556-x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1868-310X
ispartof Journal of community genetics, 2022-02, Vol.13 (1), p.13-18
issn 1868-310X
1868-6001
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8491183
source Open Access: PubMed Central; Springer Nature
subjects Biomedical and Life Sciences
Biomedicine
Epidemiology
Gene Function
Gene Therapy
Genomics
Health care
Human Genetics
Original
Original Article
Patients
Public Health
Reclassification
title Fragmented responsibility: views of Israeli HCPs regarding patient recontact following variant reclassification
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T23%3A43%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fragmented%20responsibility:%20views%20of%20Israeli%20HCPs%20regarding%20patient%20recontact%20following%20variant%20reclassification&rft.jtitle=Journal%20of%20community%20genetics&rft.au=Fridman,%20Alma%20Levin&rft.date=2022-02-01&rft.volume=13&rft.issue=1&rft.spage=13&rft.epage=18&rft.pages=13-18&rft.issn=1868-310X&rft.eissn=1868-6001&rft_id=info:doi/10.1007/s12687-021-00556-x&rft_dat=%3Cproquest_pubme%3E2579379892%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c474t-867792e8ccf67a29ee6335ac747256c91d7c872c8a1b6933d5fae8535c8dd9ee3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2623605355&rft_id=info:pmid/34609721&rfr_iscdi=true